AAAAAA
Results:
1-20
|
Results: 20
Authors:
CREMERIUS U
NEUERBURG J
ZIMNY M
OSIEKA R
BUELL U
Citation: U. Cremerius et al., FDG-PET FOR DETECTION OF RESIDUAL DISEASE AFTER THERAPY OF MALIGNANT-LYMPHOMA, The Journal of nuclear medicine, 39(5), 1998, pp. 1114-1114
Authors:
OSIEKA R
Citation: R. Osieka, PALLIATIVE CANCER-CHEMOTHERAPY, Zentralblatt fur Chirurgie, 123(6), 1998, pp. 714-721
Authors:
THILL R
NEUERBURG J
FABRY U
CREMERIUS U
WAGENKNECHT G
HELLWIG D
OSIEKA R
GUNTHER R
BULL U
Citation: R. Thill et al., COMPARISON OF 18-FDG PET AND CT FOR PRETH ERAPEUTIC STAGING OF MALIGNANT-LYMPHOMA, Nuklearmedizin, 36(7), 1997, pp. 234-239
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., APOPTOSIS AND RESISTANCE TO DAUNORUBICIN IN HUMAN LEUKEMIC-CELLS, Leukemia, 11(7), 1997, pp. 1180-1186
Authors:
OSIEKA R
Citation: R. Osieka, ONCOLOGY, Arzneimittel-Forschung, 47(10), 1997, pp. 1161-1165
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., ANTI-FAS APO-1 MONOCLONAL-ANTIBODY CH-11 DEPLETES GLUTATHIONE AND KILLS MULTIDRUG-RESISTANT HUMAN LEUKEMIC-CELLS/, Blood cells, molecules, & diseases, 22(1), 1996, pp. 2-9
Authors:
OSIEKA R
Citation: R. Osieka, THERAPEUTIC FAILURE AND DRUG-RESISTANCE, Onkologie, 19, 1996, pp. 1-2
Authors:
OSIEKA R
Citation: R. Osieka, RESISTANCE TO ANTINEOPLASTIC AGENTS IS MULTIFACETED - 3RD INTERNATIONAL MEETING ON DRUG-RESISTANCE - INTRODUCTION, Onkologie, 19, 1996, pp. 5-5
Authors:
DEMULDER PHM
WEISSBACH L
JAKSE G
OSIEKA R
BLATTER J
Citation: Phm. Demulder et al., GEMCITABINE - A PHASE-II STUDY IN PATIENTS WITH ADVANCED RENAL-CANCER, Cancer chemotherapy and pharmacology, 37(5), 1996, pp. 491-495
Authors:
ROHDE D
DEMULDER PHM
WEISSBACH L
OSIEKA R
BLATTER J
JAKSE G
Citation: D. Rohde et al., EXPERIMENTAL AND CLINICAL EFFICACY OF 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) AGAINST RENAL-CELL CARCINOMA, Oncology, 53(6), 1996, pp. 476-481
Authors:
EFFERTH T
RUCKER G
FALKENBERG M
MANNS D
OLBRICH A
FABRY U
OSIEKA R
Citation: T. Efferth et al., DETECTION OF APOPTOSIS IN KG-1A LEUKEMIC-CELLS TREATED WITH INVESTIGATIONAL DRUGS, Arzneimittel-Forschung, 46(2), 1996, pp. 196-200
Authors:
DUBOIS A
VACH W
CRAMERGIRAUD U
THOMSSEN C
GLAUBITZ M
FIOLA M
AUGENER W
BARTSCH W
BERGMANN F
BIERBAUM W
KRAPP J
BONING L
BONGARTZ U
BRUNTSCH U
VONBULTZINGSLOWEN F
DIETL J
FUGER T
FULLE HH
GATZEMEIER U
GROPP C
HARTLAPP H
HERSCHLEIN HJ
HOLTKAMP W
HURST U
JANICKE F
KAUKEL E
KLEEBERG U
ENGEL E
KRAFFT W
KUHNLE H
LINDEMANN H
MARSCHNER N
MEERPOHL HG
NIEDERLE N
OSIEKA R
PLANKER M
RIESS H
SCHMIDT M
SCHMOLL HJ
SCHUNEMANN H
WEINGARTJESSE B
WEITZEL H
WESTERHAUSEN M
WINKELMANN M
Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651
Authors:
EFFERTH T
FABRY U
GLATTE P
OSIEKA R
Citation: T. Efferth et al., INCREASED INDUCTION OF APOPTOSIS IN MONONUCLEAR-CELLS OF A GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENT PATIENT, Journal of molecular medicine, 73(1), 1995, pp. 47-49
Authors:
EFFERTH T
FABRY U
OSIEKA R
Citation: T. Efferth et al., IS THERE A REALISTIC CHANCE FOR THE CLINICAL MODULATION OF MULTIDRUG-RESISTANCE, Onkologie, 18(3), 1995, pp. 258-260
Authors:
BUSSING A
KLOTZ M
SUZART K
EFFERTH T
GERLACH D
SCHNITZLER N
OSIEKA R
SCHWEIZER K
KAUFHOLD A
Citation: A. Bussing et al., SISTER-CHROMATID EXCHANGE INDUCING DNA LESIONS AND DEPRESSION OF ACTIVATION MARKERS ON THE SURFACE OF CULTURED PERIPHERAL-BLOOD MONONUCLEAR-CELLS AFTER THE ADDITION OF STREPTOCOCCAL PYROGENIC EXOTOXIN-A AND EXOTOXINC, Medical microbiology and immunology, 184(2), 1995, pp. 87-96
Authors:
EFFERTH T
FABRY U
GLATTE P
OSIEKA R
Citation: T. Efferth et al., EXPRESSION OF APOPTOSIS-RELATED ONCOPROTEINS AND MODULATION OF APOPTOSIS BY CAFFEINE IN HUMAN LEUKEMIC-CELLS, Journal of cancer research and clinical oncology, 121(11), 1995, pp. 648-656
Authors:
BARES R
ALTEHOEFER C
CREMERIUS U
HANDT S
OSIEKA R
MITTERMAYER C
BUELL U
Citation: R. Bares et al., FDG-PET FOR METABOLIC CLASSIFICATION OF RESIDUAL LYMPHOMA MASSES AFTER CHEMOTHERAPY, The Journal of nuclear medicine, 35(5), 1994, pp. 160000131-160000131
Authors:
EFFERTH T
OSIEKA R
Citation: T. Efferth et R. Osieka, CLINICAL RELEVANCE OF THE MDR-1 GENE AND ITS GENE-PRODUCT, P-GLYCOPROTEIN, FOR CANCER-CHEMOTHERAPY - A METAANALYSIS, Tumordiagnostik & Therapie, 14(6), 1993, pp. 238-243
Authors:
BARES R
DEMPKE W
HANDT S
GALONSKA P
BUELL U
OSIEKA R
MITTERMAYER C
Citation: R. Bares et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY (SRS) IN MALIGNANT-LYMPHOMA (ML) -1ST RESULTS AND COMPARISON WITH CT AND POSITRON-EMISSION-TOMOGRAPHY (PET) WITH F-18 LABELED DEOXYGLUCOSE (FDG), The Journal of nuclear medicine, 34(5), 1993, pp. 164-164
Authors:
BARES R
GALONSKA P
DEMPKE W
HANDT S
BULL U
OSIEKA R
Citation: R. Bares et al., SOMATOSTATIN RECEPTOR SCINTIGRAPHY IN MALIGNANT-LYMPHOMA - 1ST RESULTS AND COMPARISON WITH GLUCOSE-METABOLISM MEASURED BY POSITRON-EMISSIONTOMOGRAPHY, Hormone and Metabolic Research, 27, 1993, pp. 56-58
Risultati:
1-20
|